These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28964340)

  • 1. Measurement of intracellular Ca
    Ashokan A; Aradhyam GK
    Methods Cell Biol; 2017; 142():59-66. PubMed ID: 28964340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of Ca
    Ma Q; Ye L; Liu H; Shi Y; Zhou N
    Expert Opin Drug Discov; 2017 May; 12(5):511-523. PubMed ID: 28277837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring β-arrestin recruitment via β-lactamase enzyme fragment complementation: purification of peptide E as a low-affinity ligand for mammalian bombesin receptors.
    Ikeda Y; Kumagai H; Okazaki H; Fujishiro M; Motozawa Y; Nomura S; Takeda N; Toko H; Takimoto E; Akazawa H; Morita H; Suzuki J; Yamazaki T; Komuro I; Yanagisawa M
    PLoS One; 2015; 10(6):e0127445. PubMed ID: 26030739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Structural Insights into GPCR-β-Arrestin Interaction and Signaling.
    Ranjan R; Dwivedi H; Baidya M; Kumar M; Shukla AK
    Trends Cell Biol; 2017 Nov; 27(11):851-862. PubMed ID: 28651823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.
    Park JY; Lee SY; Kim HR; Seo MD; Chung KY
    Arch Pharm Res; 2016 Mar; 39(3):293-301. PubMed ID: 26825061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin binding to human APJ receptor leads to biased signaling.
    Kumar P; Ashokan A; Aradhyam GK
    Biochim Biophys Acta; 2016 Dec; 1864(12):1748-1756. PubMed ID: 27671350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid fluorogenic GPCR-β-arrestin interaction assay.
    Zhang Q; Zheng YW; Coughlin SR; Shu X
    Protein Sci; 2018 Apr; 27(4):874-879. PubMed ID: 29411438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor regulates extracellular signal regulated kinase by two modes of arrestin binding.
    Jung SR; Kushmerick C; Seo JB; Koh DS; Hille B
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5579-E5588. PubMed ID: 28652372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of GPCR-protein interactions by BRET.
    Kocan M; Pfleger KD
    Methods Mol Biol; 2011; 746():357-71. PubMed ID: 21607868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
    Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
    Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-arrestin signaling and regulation of transcription.
    Ma L; Pei G
    J Cell Sci; 2007 Jan; 120(Pt 2):213-8. PubMed ID: 17215450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Arrestin-Dependent Dopaminergic Regulation of Calcium Channel Activity in the Axon Initial Segment.
    Yang S; Ben-Shalom R; Ahn M; Liptak AT; van Rijn RM; Whistler JL; Bender KJ
    Cell Rep; 2016 Aug; 16(6):1518-1526. PubMed ID: 27452469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation.
    Shimizu Y; Koyama R; Kawamoto T
    Biochem Pharmacol; 2017 Sep; 140():105-114. PubMed ID: 28619258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
    Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
    Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of Intracellular Ca
    Chang Y; Yi JY; Brotto M; Pan Z
    Methods Mol Biol; 2024; 2816():69-75. PubMed ID: 38977589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To sense or not to sense-new insights from GPCR-based and arrestin-based biosensors.
    Haider RS; Godbole A; Hoffmann C
    Curr Opin Cell Biol; 2019 Apr; 57():16-24. PubMed ID: 30408632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery.
    Kongsamut S; Eishingdrelo H
    Drug Discov Today; 2023 Aug; 28(8):103641. PubMed ID: 37236523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly conserved glycine within linker I and the extreme C terminus of G protein alpha subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity.
    Kostenis E; Martini L; Ellis J; Waldhoer M; Heydorn A; Rosenkilde MM; Norregaard PK; Jorgensen R; Whistler JL; Milligan G
    J Pharmacol Exp Ther; 2005 Apr; 313(1):78-87. PubMed ID: 15615862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation.
    Eichel K; Jullié D; von Zastrow M
    Nat Cell Biol; 2016 Mar; 18(3):303-10. PubMed ID: 26829388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.